Seeking Alpha

  Sophiris Bio - NASDAQ

10/23/2014, 10:29 AM ET
  • DNA Decoder | Send Message 20 Jun

    I just bought more $SPHS shares @ $2.20
    Reply (1)
    • DNA Decoder | Send Message 22 Sep
      : Sold today @$2.89 for 17% profit.
      SPHS vs. ETF Alternatives
      Company Description
      Sophiris Bio Inc is a clinical-stage biopharmaceutical company. The Company is engaged in research and development of products for the treatment of urological diseases. It is currently developing PRX302 for treatment of benign prostatic hyperplasia.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States